Sponsor content
193 result(s) found, displaying 61 to 70
-
Australian public assessment report (AusPar)Omvoh (mirikizumab) has been approved for the treatment of moderately to severely active ulcerative colitis in adult patients
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
Cancellation by sponsorRequested by Eli Lilly Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 12.5 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 15 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 10 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 2.5 mg/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MOUNJARO tirzepatide 5 mg/0.5 mL solution for injection pre-filled pen.